IL313009B1 - Collagen 1 translation inhibitors and methods of use thereof - Google Patents
Collagen 1 translation inhibitors and methods of use thereofInfo
- Publication number
- IL313009B1 IL313009B1 IL313009A IL31300924A IL313009B1 IL 313009 B1 IL313009 B1 IL 313009B1 IL 313009 A IL313009 A IL 313009A IL 31300924 A IL31300924 A IL 31300924A IL 313009 B1 IL313009 B1 IL 313009B1
- Authority
- IL
- Israel
- Prior art keywords
- collagen
- methods
- translation inhibitors
- inhibitors
- translation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL313009A IL313009B1 (en) | 2024-05-21 | 2024-05-21 | Collagen 1 translation inhibitors and methods of use thereof |
| PCT/US2025/030095 WO2025245046A1 (en) | 2024-05-21 | 2025-05-20 | Collagen 1 translation inhibitors and methods of use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL313009A IL313009B1 (en) | 2024-05-21 | 2024-05-21 | Collagen 1 translation inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL313009A IL313009A (en) | 2025-12-01 |
| IL313009B1 true IL313009B1 (en) | 2026-01-01 |
Family
ID=97796035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL313009A IL313009B1 (en) | 2024-05-21 | 2024-05-21 | Collagen 1 translation inhibitors and methods of use thereof |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL313009B1 (en) |
| WO (1) | WO2025245046A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021216665A1 (en) * | 2020-04-22 | 2021-10-28 | Anima Biotech Inc. | Collagen 1 translation inhibitors and methods of use thereof |
-
2024
- 2024-05-21 IL IL313009A patent/IL313009B1/en unknown
-
2025
- 2025-05-20 WO PCT/US2025/030095 patent/WO2025245046A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021216665A1 (en) * | 2020-04-22 | 2021-10-28 | Anima Biotech Inc. | Collagen 1 translation inhibitors and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| IL313009A (en) | 2025-12-01 |
| WO2025245046A1 (en) | 2025-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4139291A4 (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| IL308041A (en) | Collagen compositions and methods of use thereof | |
| IL319748A (en) | Pcsk9 inhibitors and methods of use thereof | |
| IL313009B1 (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| IL310685B2 (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| CA3257282A1 (en) | Collagen compositions and methods of use thereof | |
| IL314277A (en) | Anti-b7-h3 compounds and methods of use | |
| HK40083510A (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| HK40083533A (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| HK40080159A (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| EP4097084A4 (en) | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE | |
| LT4554562T (en) | Olanzapine compositions and methods of use | |
| GB202312186D0 (en) | Kit of parts and method | |
| GB202406144D0 (en) | Composition and method of use | |
| GB202408324D0 (en) | Inhibitors of expression and/or function | |
| IL310211A (en) | Porcine collagen compositions and methods of use thereof | |
| GB202507080D0 (en) | Compositions and method of use relating thereto | |
| GB202416740D0 (en) | Anchor apparatus and/or method of use thereof | |
| GB202509578D0 (en) | Composition and method of treatment | |
| GB202504281D0 (en) | Composition and method of treatment | |
| GB202403805D0 (en) | Compositions and methods of treatment | |
| ZA202201808B (en) | Preparation method and application of collagen peptide chelated ferrous hydrogel | |
| GB202511967D0 (en) | Compositions and methods of using same | |
| GB202313643D0 (en) | Serping1-sarna compositions and methods of use | |
| GB202310868D0 (en) | compositions and methods of use |